Detalles de la búsqueda
1.
Spatially preserved multi-region transcriptomic subtyping and biomarkers of chemoimmunotherapy outcome in extensive-stage small cell lung cancer.
Clin Cancer Res
; 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630755
2.
Real-world Data of Paclitaxel and Cetuximab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck.
Cancer Diagn Progn
; 3(2): 264-271, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36875311
3.
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05).
J Clin Oncol
; 41(28): 4478-4485, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37603816
4.
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial.
Clin Transl Med
; 11(7): e491, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34323406
5.
Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02).
Anticancer Drugs
; 18(10): 1201-6, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17893521
6.
Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).
Anticancer Drugs
; 15(5): 489-94, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15166623
Resultados
1 -
6
de 6
1
Próxima >
>>